PTPN2 and colitis: Based on published evidence that Jaks and STAT pathways negatively regulate inflammatory bowel diseases like colitis in Crohn's disease and ulcerative coloitis [1]–[7], we pursued the possibility that DSS treatment was also initiating systemic inflammation in TC-PTP+/− mice.